Acute Kidney Injury Treatment MarketThe global Acute Kidney Injury (AKI) Treatment Market is poised for significant growth, ...

Drug-induced AKI (acute kidney injury) is common and may include medications not previously known to exhibit this safety signal.

AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as ...

The following is a summary of “Impact of AKI on metabolic compensation for respiratory acidosis in ICU patients with AECOPD,” ...

We are thankful for the steady pace of site activations and continued brisk enrollment with our recently activated sites already contributing,” said Kevin Chung, MD, Chief Medical Officer of SeaStar ...

Bone fracture may be among the adverse outcomes of acute kidney injury (AKI), investigators suggest. In a retrospective study of 123,426 Australian adults, 14,549 (12%) experienced an AKI episode and ...

Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the treatment of ...

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive heart failure. Reports of GLP-1RA–associated acute ...

Outcomes study will assess mortality and hospitalization in patients treated with Vafseo compared to current standard of care "We look forward to begin treating CKD anemia patients on dialysis with ...